Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses
The Journal of Immunology · 15.04.2026 · 215 (4)
DOI: 10.1093/jimmun/vkaf335 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 27.04.2026. Verfasst von Camila Medeiros Costa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitárias, Instituto René Rachou/Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Plasmodium vivax, CD4-Positive T-Lymphocytes, Epitopes, T-Lymphocyte. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Amazonian Center of Excellence in Malaria Research, Brazilian National Institute of Science and Technology for Vaccines.
Abstract (Originalsprache)
Malaria remains a significant public health concern despite a steady decline in symptomatic cases. In Brazil, endemic regions are primarily concentrated in the Amazon region, where most cases are attributed to Plasmodium vivax. Although malaria does not confer long-term sterilizing immunity, clinical immunity is achieved, leading to asymptomatic (ASY) infections. Assessing cellular immunity against P. vivax is challenging due to the lack of well-defined antigens. Hence, we developed a library of 310 P. vivax peptides (MPv310) to evaluate antigen-specific responses of CD4+ T cells and their memory subpopulations. The specific cytokine response, IFN-γ and TNF, and upregulation of activation markers, CD69 and CD154, were assessed in P. vivax–infected individuals, including symptomatic before treatment (SY-I) patients, symptomatic after treatment (SY-T) patients, ASY individuals, and uninfected individuals. CD4+ T cells were stimulated with peptides and analyzed by flow cytometry or ELISpot. MPv310 stimulation led to increased frequencies of CD154+ and CD69+CD154+ cells in symptomatic before treatment and SY-T patients and IFN-γ+TNF+ cells in SY-T patients. Cytokine response was also associated with ASY status, with higher frequencies of IFN-γ+TNF+ among CD4+ T cells and of IFN-γ+ in the effector memory subset. Distinct antigen-specific activation patterns were also observed among symptomatic and ASY individuals when the peptide pool was divided into smaller pools representing specific antigens. This study reveals that MPv310 and different sets of minipools stimulate CD4+ T cells in symptomatic and ASY infections, having potential to be used as a new tool to assess immune mechanisms associated with different clinical presentations of the disease and protection against malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitárias, Instituto René Rachou/Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
- Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, United States.
- Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
- Laboratório de Bioinformática e Análises Moleculares, Universidade Federal de Uberlândia, Patos de Minas, Minas Gerais, Brazil.
- Ambulatório de Malária, Centro de Pesquisa em Medicina Tropical, Porto Velho, Rondônia, Brazil.
- Grupo Integrado de Biomarcadores, Instituto René Rachou/Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
ORCID-Profile: Camila Medeiros Costa
Förderung
- NIH HHS
- Amazonian Center of Excellence in Malaria Research
- Brazilian National Institute of Science and Technology for Vaccines
- CNPq
- Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior
- Inova Fiocruz
- National Institutes of Health
Zitieren
APA
Costa, C. M., Almeida, G. G., Lindestam Arlehamn, C. S., Queiroz-Glauss, C. P., Gunderman, V. H. G., Pereira, M. M. M., Amaral, L. R. D., Pereira, D. B., Tada, M. S., Martins-Filho, O. A., Gazzinelli, R. T., & Antonelli, L. R. D. V. (2026). Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses. The Journal of Immunology, 215(4). https://doi.org/10.1093/jimmun/vkaf335
Vancouver
Costa CM, Almeida GG, Lindestam Arlehamn CS, Queiroz-Glauss CP, Gunderman VHG, Pereira MMM, et al. Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses. The Journal of Immunology. 2026;215(4). doi:10.1093/jimmun/vkaf335
BibTeX
@article{Costa2026,
author = {Costa, Camila Medeiros and Almeida, Gregório Guilherme and Lindestam Arlehamn, Cecília S and Queiroz-Glauss, Camila Pereira and Gunderman, Victor Hugo Gonçalves and Pereira, Marcela Marísia Mayrink and Amaral, Laurence Rodrigues Do and Pereira, Dhelio Batista and Tada, Mauro Shugiro and Martins-Filho, Olindo Assis and Gazzinelli, Ricardo Tostes and Antonelli, Lis Ribeiro Do Valle},
title = {Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {4},
doi = {10.1093/jimmun/vkaf335}
}
EUVIMED